Opinion|Videos|January 27, 2026

Veda Giri, MD, on patient-reported outcomes with prostate cancer genetic testing

Fact checked by: Hannah Clarke

Veda N. Giri, MD, shares key findings from the PROGRESS Registry, which evaluated patient-reported outcomes with prostate cancer genetic testing.

Recent results from the PROGRESS Registry offer insights into men’s experience with genetic testing for prostate cancer.1 In a recent interview with Urology Times®, senior author Veda N. Giri, MD, discusses the design and key findings from the study.

Giri is a professor of internal medicine (medical oncology) at Yale School of Medicine as well as the Director of the Early Onset Cancer Program and Assistant Director of the Clinical Cancer Genetics Program at Yale Cancer Center and Smilow Cancer Hospital in New Haven, Connecticut.

REFERENCE

1. Loeb S, Keith SW, Gross L, et al. Patient-Reported Outcomes From Males Regarding Germline Testing for Prostate Cancer: Results From the PROGRESS Registry. JCO Precis Oncol. 2025:9:e2500571. doi: 10.1200/PO-25-00571

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

Subscribe Now!

Related Content

Latest CME

Breakthroughs in Non–Muscle-Invasive Bladder Cancer: Advancing Patient Care Through Innovation in Treatment
Virtual Event

Breakthroughs in Non–Muscle-Invasive Bladder Cancer: Advancing Patient Care Through Innovation in Treatment

February 23, 2026

View more
Case-by-Case: Application of HIF-PHIs for the Treatment of Anemia in Patients With CKD
Video

Case-by-Case: Application of HIF-PHIs for the Treatment of Anemia in Patients With CKD

Glenn M. Chertow, MD, MPH; Anil K. Agarwal, MD, FACP, FASN, FNKF, FASDIN; Preethi Yerram, MD

View more